Chiara Lorubbio

Metastasis-directed therapy and standard of care versus standard of care for oligometastatic prostate cancer (WOLVERI...

ADT with SBRT versus SBRT alone for hormone-sensitive oligorecurrent prostate cancer (RADIOSA): a randomised, open-la...